A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Continuing Medical Education

Continuing Medical Education
City of Hope has a long-standing commitment to continuing medical education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.

CME events are vital for physicians seeking board certification and for maintenance of certification, or MOC, ensuring that they are kept up to date on the latest treatment modalities and delivering the highest standard of patient care.
One of the Top ACCME-accredited CME Program Providers

City of Hope’s CME program has been fully accredited since 1999 through the Accreditation Council for Continuing Medical Education (ACCME) to provide AMA PRA Category 1 CreditTM. In 2005, our CME Program received its first Accreditation with Commendation. This designation placed our CME Program in the top 1 to 2 percent of CME program providers in the nation. In 2011, the ACCME awarded our CME Program its second consecutive Accreditation with Commendation designation citing compliance in all 22 Criteria and Accreditation Policies and characterizing our CME Program as having "...demonstrated an engagement with your environment in support of physician learning and change that is part of a system of quality improvement."
A Founding Member of NCCN

City of Hope is a founding member of the NCCN (National Comprehensive Cancer Network), a not-for-profit alliance of 21 of the nation’s leading cancer centers. The NCCN develops clinical practice guidelines for use by patients, physicians and other health care decision-makers. The NCCN Drugs and Biologics Compendium is a regularly-updated, comprehensive set of guidelines which recommends the most appropriate diagnostic tests, therapy and follow-up for cancer patients based on clinical evidence as well as the consensus of leading academic cancer centers.

City of Hope’s expert doctors contribute to the NCCN Compendium on an ongoing basis, and CME courses offered by City of Hope are consistently informed by NCCN guidelines.

CME e-Learning

City of Hope's Department of Continuing Medical Education offers accredited e-Learning courses/programs in addition to conferences and symposiums.

Immunization Initiative

City of Hope has undertaken an Immunization Initiative to help both healtcare providers and patients more aware of the need to be current with immunizations. Many adults assume that immunizations they received as children will protect them for a lifetime. While this is true for some vaccinations, oncologists, primary care physicians, and others who manage patients with cancer need to be aware that some adults have never received certain childhood immunizations and that newer accines may not have been available to them as children. Furthermore, immunity conferred by some vaccines fades over time, an effect that may be exacerbated in patients with cancer or who might be otherwise immunocompromised.
Questions regarding this project or to learn how to get involved please contact the Continuing Medical Education Department at 626-256-4673 ext 65622 or email us at cme@coh.org.
The education and information provided has been developed in collaboration between City of Hope and The France Foundation and sponsored by an educational research grant by Pfizer.


Support Materials

VTE Prophylaxis

Patients with cancer, particularly those undergoing active treatment, frequently experience thromboembolic events. Despite the availability of many guidelines for VTE prohylaxis data demonstrate that there is a discordance between guidelines and practice. In point of fact, VTE is a leading cause of morbidity in patients with cancer.
To support our staff in the furtherance of excellent treatment provided by City of Hope, the Department of Continuing Medical Education will release an accredited series of educational interventions the focus of which will be the prevention and decrease of Venous Thromboembolic Events.
This series has been made possible by support from the Unihealth Foundation.
On the Go
Hear what experts have to say about Venous Thromboembolic Events. The following can be completed in 20 minutes or less.

More Time

Receive Credit
To receive AMA PRA Category 1 Credit(s)tm you must:
  1. Register for each individual program
  2. View course materials
  3. Pass each post test with 70% or better
  4. Complete the activity evaluation
If you have any questions regarding credits, please contact the Department of Continuing Medical Education at : 626-256-4673 ext 65622 or cme@coh.org.

Clinical Updates

City of Hope Continuing Medical Education Department is committed to providing you with the information and resources to facilitate improvement in practice performance patient outcomes.

Please review the the links below:

Contact the Continuing Medical Education Department if you have questions regarding this or any of the information provided at cme@coh.org or 626-256-4673 ext 65622.

Grand Rounds

The Grand Rounds program offered at City of Hope is available to physicians and hospitals in the surrounding areas. Members of the medical staff at City of Hope are available to speak to medical groups, hospital medical staffs and community hospital health-care professionals on a variety of topics related to cancer and other life-threatening diseases. Our speakers can provide expert presentations in various settings, including hospital grand rounds, luncheon and dinner lectures, and CME conferences and symposia. New speakers and topics are added regularly, and we can create custom presentations to meet the specific needs of your organization.
Anatomic Pathology
Central Nervous System
Brain Tumors, Benign
Brain Tumors, Malignant
Brain Tumors, Metastatic
CNS Lymphoma
Pituitary Tumors
Spinal Tumors

Clinical Cancer Genetics
Genetic Counseling
Clinical Molecular Diagnostics
Advances in Testing
Familial Cancer Testing
Hereditary Colon Cancer
Li-Fraumeni Syndrome (the largest clinical experience to date)
Marfan Syndrome
X-link Mental Retardation (a panel of eight genes may detect the underlying mechanism in about 20 percent of families)
Islet Cell Transplantation
Gastrointestinal Cancers
Anal Cancer
Bile Duct Cancer
Colon Cancer
Esophageal Cancer
Gallbladder Cancer
Gastric Cancer
Gastrointestinal Carcinoid Tumors
Liver Cancer
Pancreatic Cancer
Rectal Cancer
Small Intestine Cancer

Genitourinary Cancers
Bladder Cancer
Kidney Cancer
Prostate Cancer
Testicular Cancer
Head and Neck Cancers
Laryngeal Cancer
Oral Cancer

Hematologic Malignancies
Aplastic Anemia
Hematopoietic Stem Cell Transplantation
Leukemia, Acute Lymphoblastic
Leukemia, Acute Myeloid
Leukemia, Acute Promyelocytic
Leukemia, Chronic Lymphocytic
Leukemia, Chronic Myelogenous
Lymphoma, Primary CNS
Lymphoma, Hodgkin’s
Lymphoma, Non-Hodgkin’s
Multiple Myeloma
Myelodysplastic Syndromes
Plasma Cell Neoplasms

Infectious Diseases
Worldwide Swine Flu (AH1N1) Outbreak - CME Module
Musculoskeletal Cancers
Bone and Soft Tissue
Sarcomas and Other Soft Tissue Cancers
Myasthenia Gravis
Robotic Thymectomy
Pain Management and Palliative Care
Pediatric Cancers
Bone and Soft Tissue Cancer
Childhood Brain Tumor
Leukemia, Childhood Acute Lymphoblastic
Leukemia, Childhood Acute Myeloid
Liver Cancer, Childhood
Lymphoma, Childhood Hodgkin’s Disease
Lymphoma, Childhood Non-Hodgkin’s
Skin Cancer

Thoracic Cancers
Lung Cancer, Non-small Cell
Lung Cancer, Small Cell
Mediastinal Tumors

Thyroid Cancer

Women’s Cancers
Breast Cancer
Cervical Cancer
Endometrial/Uterine Cancer
Ovarian Epithelial Cancer
Ovarian Germ Cell Tumor
In addition to those shown here, speakers on a variety of other topics are available. Please contact us for more information.



Accreditation History

We at the City of Hope have had an active Continuing Medical Education program since the 1950's when the school of Postgraduate Medicine first sponsored extramural conferences. Our first accreditation occurred under the aegis of the California Medical Association in 1978. We continued this statewide accreditation until our expanding national course offerings and reputation evolved into an application for national accreditation in 1997. In July 1999, a two-year provisional accreditation status was awarded through ACCME (Accreditation Council for Continuing Medical Education).

In February 2005, our CME Program underwent the ACCME’s rigorous quadrennial reaccreditation review and survey. We were advised by ACCME on July 15, 2005 that we had been Reaccredited with Commendation with Exemplary Compliance demonstrated in six Essential Elements. This designation placed our CME Program in the top one to two percent of CME program providers in the nation. We were also listed as a “best practices” resource on the ACCME website under their Exemplary Compliance List.

On February 24, 2011, our City of Hope CME Program once again underwent ACCME re-accreditation review. On July 22, 2011, the ACCME apprised us of their decision to award our program its second consecutive Accreditation with Commendation citing compliance in all 22 Criteria and Accreditation Policies and characterizing our CME Program as having "...demonstrated an engagement with your environment in support of physician learning and change that is part of a system of quality improvement."



CME Calendar

City of Hope's CME calendar is easy to navigate - just move your cursor over or click a date or event description. You can also add events to your personal calendar, e-mail event information to yourself or others, set up e-mail and cell phone text message reminders on events and other event actions. Additionally, you can subscribe to the CME calendar in different ways including Weekly e-mails, RSS and Atom Feeds.

CME Dinner Series

Regional continuing medical education (CME) events welcome physicians from the surrounding areas for focused sessions on current oncology topics.

Dinner Meeting Series
City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

City of Hope designates this educational activity for a maximum of1.5AMA PRA Category 1 Credit™.Physicians should only claim credit commensurate with the extent of their participation in the activity.
You also have the opportunity of addingevents from the CME Dinner Series Calendar directly to your personal calendar as well as send reminders to yourself. (See Event Actions below calendar.)
Conference Contact
For additional information, please contact course registrar at 626-256-HOPE (4673), Ext. 65622


National and Regional Events and Conferences
City of Hope's Department of Continuing Medical Education now offers accredited e-Learning courses/programs in addition to conferences and symposiums.

Learn more about
City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Ranked as one of “America’s Best Hospitals” in cancer by U.S.News & World Report, City of Hope is a pioneer in the fields of hematopoietic cell transplantation and genetics. Designated as a comprehensive cancer center, the highest honor bestowed by the National Cancer Institute, City of Hope's research and treatment protocols advance care throughout the nation.
Grand Rounds
Grand Rounds
The Grand Rounds program offered at City of Hope is available to physicians and hospitals in the surrounding areas. Members of the City of Hope medical staff are available to speak on a variety of topics related to cancer and other life-threatening diseases.
  • For breast cancer survivors, a common worry is a recurrence of their cancer. Currently, these patients are screened with regular mammograms, but there’s no way to tell who is more likely to have a recurrence and who is fully cleared of her cancer. A new blood test – reported in Cancer Research, a journal of the...
  • Metastasis — the spreading of cancer cells from a primary tumor site to other parts of the body — generally leads to poorer outcomes for patients, so oncologists and researchers are constantly seeking new ways to detect and thwart this malicious process. Now City of Hope researchers may have identified a substa...
  • Deodorant, plastic bottles, grilled foods, artificial sweeteners, soy products … Do any of these products really cause cancer? With so many cancer myths and urban legends out there, why not ask the experts? They can debunk cancer myths while sharing cancer facts that matter, such as risk factors, preventi...
  • Cancer risk varies by ethnicity, as does the risk of cancer-related death. But the size of those differences can be surprising, highlighting the health disparities that exist among various ethnic groups in the United States. Both cancer incidence and death rates for men are highest among African-Americans, acco...
  • George Winston, known worldwide for his impressionistic, genre-defying music, considers music to be his first language, and admits he often stumbles over words – especially when he attempts languages other than English. There’s one German phrase he’s determined to perfect, however: danke schön. Winston thinks h...
  • Few decisions are more important than those involving health care, and few decisions can have such lasting impact, not only on oneself but on relatives and loved ones. Those choices, especially, should be made in advance – carefully, deliberately, free of pain and stress, and with much weighing of values and pr...
  • Using a card game to make decisions about health care, especially as those decisions relate to the end of life, would seem to be a poor idea. It isn’t. The GoWish Game makes those overwhelming, but all-important decisions not just easy, but natural. On each card of the 36-card deck is listed what seriously ill,...
  • Young adults and adolescents with cancer face unique challenges both during their treatment and afterward. Not only are therapies for children and older adults not always appropriate for them, they also must come to terms with the disease and treatment’s impact on their relationships, finances, school or ...
  • Breast cancer is the most common cancer, other than skin cancer, among women in the United States. It’s also the second-leading cause of cancer death, behind lung cancer. In the past several years, various task force recommendations and studies have questioned the benefits of broad screening guidelines fo...
  • Paternal age and the health effects it has on potential offspring have been the focus of many studies, but few have examined the effect parental age has on the risk of adult-onset hormone-related cancers (breast cancer, ovarian cancer and endometrial cancer). A team of City of Hope researchers, lead by Yani Lu,...
  • Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal h...
  • Myeloproliferative neoplasms can’t be narrowed down to a single cancer, but they can be described by a defining characteristic: too many blood cells. The diseases bring with them a host of frustrating, potentially life-altering symptoms, and management of the diseases and their symptoms is crucial. An upcoming ...
  • More than 18,000 researchers, clinicians, advocates and other professionals will convene at the 105th American Association for Cancer Research (AACR) annual meeting taking place in San Diego from April 5 to 9. With more than 6,000 findings being presented over this five-day period, the amount of information can...
  • Cancer of the prostate is the No. 2 cancer killer of men, behind lung cancer, accounting for more than 29,000 deaths annually in this country. But because prostate cancer advances slowly, good prostate health and early detection can make all the difference. Many prostate cancer tumors don’t require immedi...
  • Despite advances made in detecting and treating nonsmall cell lung cancer, its prognosis remains grim. Even patients whose cancers are caught at their earliest stage have only a 50 percent chance of five-year survival. This poor prognosis is due in part to the cancer’s ability to resist treatment, renderi...